Showing results (181-190 of 232) with videos related to

Sort By:
Pageof 24
Cancers|April 27, 2024
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter AnalysisGrzegorz Charliński, Maximilian Steinhardt, Leo Rasche, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 8, 2013
Gain(1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomibJan Smetana, Kristina Berankova, Romana Zaoralova, et al.
Ejhaem|October 17, 2024
A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myelomaStefan Knop, Monika Szarejko, Norbert Grząśko, et al.
Leukemia & Lymphoma|July 24, 2018
Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 casesArtur Jurczyszyn, Julio Davila, K Martin Kortüm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone diseaseEvangelos Terpos, Gareth Morgan, Meletios A Dimopoulos, et al.
Leukemia|November 2, 2013
International Myeloma Working Group recommendations for global myeloma careH Ludwig, J S Miguel, M A Dimopoulos, et al.
Journal of Clinical Apheresis|September 19, 2017
Stem cell mobilization in patients with dialysis-dependent multiple myeloma: Report of the Polish Myeloma Study GroupAnna Waszczuk-Gajda, Joanna Drozd-Sokołowska, Piotr Boguradzki, et al.
American Journal of Hematology|July 24, 2019
Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patientsIrit Avivi, Yael C Cohen, Anna Suska, et al.
European Journal of Haematology|May 26, 2018
Autologous peripheral blood stem cell transplantation in dialysis-dependent multiple myeloma patients-DAUTOS Study of the Polish Myeloma Study GroupAnna Waszczuk-Gajda, Zbigniew Lewandowski, Joanna Drozd-Sokołowska, et al.
British Journal of Haematology|September 30, 2016
Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control studyArtur Jurczyszyn, Hareth Nahi, Irit Avivi, et al.
Pageof 24